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Meniscus integrity is the key for joint health of the knee. Therefore, the main goal of every meniscus treatment
should be the maintenance of as much meniscus tissue as possible.
Repair of meniscus tears can be achieved by meniscus suture. However, in a recently published meta-analysis, the
long-term outcome of meniscus repair showed a mean failure rate of 24%.
In a preclinical trial, locally applied mesenchymal stem cells produced differentiated meniscus-like tissue in meniscus
tears indicating that mesenchymal-based cells, harvested from the bone marrow, enhance meniscus healing in
critical-size meniscus tears.
Symptomatic meniscus defects offer the option for meniscus transplantation with porous cell free biomaterials,
when a complete meniscus rim is available. Cell-free biomaterials, which are actually in clinical application, reveal
variable outcome in mid-term results from complete failure to regeneration with meniscus-like tissue.
In several preclinical studies with different critical-size defects in the meniscus, the application of mesenchymal stem
cells could significantly enhance meniscus regeneration compared to empty defects or to cell-free biomaterials.
Regenerative treatment of meniscus with mesenchymal stem cells seems to be a promising approach to treat
meniscal tears and defects. However it is still not clear, whether the stem cell effect is a direct action of the
mesenchymal-based cells or is rather mediated by secretion of certain stimulating factors. The missing knowledge
of the underlying mechanism is one of the reasons for regulatory burdens to permit these stem cell-based
strategies in clinical practice. Other limitations are the necessity to expand cells prior to transplantation resulting in
high treatment costs. Alternative treatment modalities, which use growth factors concentrated from peripheral
blood aspirates or mononucleated cells concentrated from bone marrow aspirates, are currently in development
in order to allow an attractive one-step procedure without the need for cell expansion in cultures and thus lower
efforts and costs.
In summary, Tissue Engineering of meniscus with mesenchymal based cells seems to be a promising approach to
treat meniscal tears and defects in order to restore native meniscus tissue. However, advances of the technology
are necessary to allow clinical application of this modern regenerative therapy.
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Meniscal lesions represent the most common intra-
articular knee injury, and are the most frequent cause of
surgical procedures performed by orthopaedic surgeons
(Makris et al. 2011). The mean annual incidence of
meniscal lesions has been reported to be 66 per 100.000
inhabitants, 61 of which result in meniscectomy (Makris
et al. 2011). The changes in “pivoting” sports activities in
the past few decades have resulted in increased injury* Correspondence: peter.angele@ukr.de
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in any medium, provided the original work is prates of the meniscus (1.5 million injuries in Germany
per year) (Stein et al. 2010). Especially in combination
with anterior cruciate ligament injuries a high incidence
of meniscal lesions (40-80%) can be detected.
Meniscus integrity is the key for joint health of the
knee. Untreated meniscus tears cause intermittent pain,
joint swelling, recurrent mechanical symptoms (clicking,
catching, giving way) and, therefore, significant reduc-
tion in quality of life in predominately young and active
patients (McDermott 2011).Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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set of joint degeneration and, finally, knee osteoarthritis
with all its consequences including pain, immobility and
knee arthroplasty (Lohmander et al. 2007; Stein et al.
2010; Borchers et al. 2011; Jeong et al. 2012; Badlani
et al. 2013). In a recent published case–control study
(Level of evidence 3) specific meniscus tear morpholo-
gies (Meniscus extrusion, complex tears, tears with large
radial involvement) have shown to be significantly more
common in patients with progressive development of
osteoarthritic changes in a 2 year follow-up indicating
that these meniscus tears represent a negative prognos-
tic risk factor for later development of osteoarthritis
(Badlani et al. 2013).
Removal of meniscus tears lead to short term relief of
clinical symptoms, but to knee osteoarthitis in long-
term (Salata et al. 2010; Paxton et al. 2011; Papalia
et al. 2011; Jeong et al. 2012). Especially the amount
meniscus removed, lateral meniscectomy and longer
duration of clinical symptoms preoperatively have been
identified as negative prognostic risk factors for the on-
set of osteoarthritis in systematic reviews (Papalia et al.
2011; Jeong et al. 2012). Elevated expression levels of
arthritis-related markers in meniscus tears in patients
under forty years old, compared to patients over forty
years, and in patients with meniscus and anterior cruci-
ate ligament tears, compared to patients with isolated
meniscus tears, indicate an increased catabolic response
suggesting a higher risk for progression of osteoarthritis
following partial meniscectomy (Brophy and Matava
2012).
Knowing the risk for the onset of osteoarthritis after
meniscectomy, the majority of meniscus tears are still
treated with partial meniscectomy as shown in a huge co-
hort of more than 1000 young patients undergoing anter-
ior cruciate ligament reconstruction (Fetzer et al. 2009).
Therefore, the main goal of every meniscus treat-
ment should be the maintenance of as much meniscus
tissue as possible (Fetzer et al. 2009; Starke et al. 2009;
Stein et al. 2010; Abrams et al. 2013). This includes re-
pair of meniscus tears and regeneration of meniscus
defects after meniscectomy with regenerative treat-
ment approaches.
In recent years, there has been a growing interest in
using mesenchymal stem cells to regenerate damaged
tissue such as injured hyaline cartilage or meniscus.
These mesenchymal stem cells fulfill a dual role for
musculoskeletal repair, because they have the potential
to differentiate into the repair cells themselves and to
produce special growth factors for its repair (Caplan and
Dennis 2006). This review focuses on the present and fu-
ture treatment options especially for meniscus repair
and meniscus regeneration given by the use of intrinsic
or exogenous applied mesenchymal stem cells.Review
Endogenous repair cells of meniscus injury
Currently, a number of potential repair cells for menis-
cus regeneration are available. Repair cells of meniscus
injury can either be located in the meniscus tissue itself
or entering the meniscus predominately via circulation.
In the following section, we will focus on the availability
of repair cells and repair potential of the meniscus.
Endogenous repair of meniscus injury seems to be
dependent of the different vascularisation of the outer
and the inner zone of the meniscus (Arnoczky 1999).
Repair in the vascularized outer zone can be achieved
(McDermott 2011), but fail to encourage healing in the
avascular inner zone of the meniscus (Hasan et al. 2014;
Makris et al. 2011). However, in several studies also re-
generation could be seen in the inner zone of the menis-
cus indicating regenerative potential independently from
the vascularization (Nakata et al. 2001; Hennerbichler
et al. 2007; Baker et al. 2009; Pabbruwe et al. 2010).
Hennerbichler et al. have shown in an experimental
setup, that punch defects, which were directly filled with
the removed punches, showed no significant difference
in healing potential between the vascularized and avas-
cularized meniscus zone (Hennerbichler et al. 2007).
Croutze and coworkers could demonstrate equivalent
differentiation potential toward chondrogenic phenotype
and extracellular matrix production of isolated human
meniscus cells from the inner and the outer zone
(Croutze et al. 2013). Different studies stated that milieu
factors like oxygen tension (Croutze et al. 2013) and
growth factors (Pabbruwe et al. 2010) may play a key
role in modulating redifferentiation of meniscal fibro-
chondrocytes at least in vitro.
From a clinical standpoint, meniscus cells from menis-
cectomised tissue would be the ideal cell source for re-
pair. Is this approach applicable? Nakata et al. have
shown feasibility of meniscus regeneration by expansion
of human meniscus cells from meniscectomised tissue
(Nakata et al. 2001). With the same cell source Baker
et al. could achieve repair tissue with equivalent mech-
anical properties than native meniscus tissue (Baker
et al. 2009). However the low proliferation rate and
matrix production limit the use of this cell type (Nakata
et al. 2001). In addition, potential candidates for menis-
cus transplantation have already undergone partial men-
iscectomy with the necessity to find alternative cell
sources.
Stem cells are characterized by self-renewal capacity
and multilineage differentiation potential to a variety of
cell types of mesenchymal tissue like bone, cartilage or
fat (Caplan 1991; Caplan and Dennis 2006). Recently,
the stem cell perspective has changed by identification of
pericytes around almost every blood vessel in the body,
which contain stem cell characteristics (Bianco et al. 2008;
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existing traditional view, which focuses on the multipotent
differentiation capacity of these cells, has been expanded
to include their equally interesting role as cellular modula-
tors that bring them into a broader therapeutic scenario
(Caplan and Correa 2011).
With this background, it is not surprising that Osawa
et al. have identified in the vascularized region of the
meniscus more blood-vessel derived stem cells (CD34-
and CD146-positive cells) than in the avascular region.
These meniscal-derived stem cells were multipotent and
contributed to meniscal regeneration, which they proof
via transplantation in knee joints of athymic rats (Osawa
et al. 2013).
Does also the avascular inner zone of the meniscus
contain stem cells? Stem cells have been identified in the
surface zone of other avascular tissue, mainly in the ar-
ticular cartilage (Archer et al. 1994; Dowthwaite et al.
2004; McCarthy et al. 2012), but little is known about
meniscus stem cells. Mauck et al. describes regional
multilineage differentiation potential of meniscus cells in
both zones available, however showed differences in
pluripotency between the zones (Mauck et al. 2007). Es-
pecially, pluripotent cells from the avascular tissue seem
to lack osteogenic differentiation potential, which could
be of clinical interest for meniscus regenerative ap-
proaches (Mauck et al. 2007; McCarthy et al. 2012).
Besides existence of mesenchymal stem cells in the
meniscus, the synovium and the synovial fluid contain
stem cells for meniscus regeneration (Sakaguchi et al.
2005; Horie et al. 2009; Matsukura et al. 2014). Matsukura
and coworkers found elevated levels of mesenchymal stem
cells in the synovium fluid after meniscus injury compared
to normal knee joints suggesting that mesenchymal
stem cells in the fluid may play a role in regeneration of
meniscus (Matsukura et al. 2014). Horie and coworkers
showed promotion of meniscal regeneration in rat massive
meniscal defects by intra-articular injection of synovial
stem cells. The injected cells adhere to the lesion site,
directly differentiate in meniscus cells and promote
meniscal regeneration without mobilization to distant
organs (Horie et al. 2009).
In summary, local or systemic stem cells seem to play
a fundamental and essential role in the regeneration of
meniscus injury, either as direct repair cells or as a
source for secretion of bioactive modulators.
Repair of meniscus tears with meniscus suture
If the meniscus repair succeeds then the patient is left
with a normal or near-normal meniscus, and thus no in-
creased risk of osteoarthritis in the future (McDermott
2011; Stein et al. 2010; Paxton et al. 2011). In a cohort
study (Level of evidence 3) no osteoarthritic progress
was detectable in 80% of the patients after meniscusrepair compared with 40% after meniscectomy in a long-
term follow-up (mean 9 years) (Stein et al. 2010). In a sys-
tematic review meniscal repair showed superior clinical
outcome detected by higher Lysholm scores and less
radiologic degeneration than meniscectomy (Paxton et al.
2011). However, in a recently published meta-analysis, the
long-term outcome of meniscal repair showed a mean fail-
ure rate of 23,1% (Nepple et al. 2012).
Augmentation of meniscus suture
Given the low healing potential of meniscus in the avas-
cular zone and the moderate healing rates of meniscus
repair in the vascular zone, there is a strong need for
true regeneration of viable and biomechanically func-
tional meniscus tissue.
Several methods have been devised to aid the healing
of the meniscus, ranging from refreshing the meniscus
tears with rasps and creation of access channels in the
meniscus base to introduce blood and reparative cells to
meniscus tears (Scotti et al. 2013) (Figure 1). The use of
fibrin clots, synovial flaps and resorbable scaffolds in or
around the tears were also described in the literature in
order to enhance meniscus healing potential (Hasan
et al. 2013; Starke et al. 2009).
Exogenous fibrin clots seem to improve healing in ani-
mal models and in humans (Starke et al. 2009). It is pos-
tulated that the clot serves as a chemotactic and
mitogenous stimulus. Platelet-rich plasma (PRP), which
contains the majority of growth factors in the peripheral
blood, seems to promote the clinical healing of meniscus
tears even in the white-white zone (Wei et al. 2012)
mainly in the earlier period after meniscal suture. How-
ever, the clinical use of this intriguing arthroscopically
applicable, one-step procedure for meniscus repair is ac-
tually not tested in prospective trials due to regulatory
burdens.
Augmentation of meniscus suture with mesenchymal
stem cells
Preclinical trials have shown enhanced healing of menis-
cal lesions with the application of mesenchymal based
cells (Table 1) (Table 2) (Hasan et al. 2013; Makris et al.
2011; Izuta et al. 2005; Angele et al. 2008; Zellner et al.
2010; Zellner et al. 2013). Locally applied expanded mes-
enchymal stem cells from the bone marrow have achieved
regeneration of longitudinal meniscus tears in the avascu-
lar zone in the lateral meniscus of New Zealand White
Rabbits. Control groups with untreated tears, treatment
with meniscus suture alone or meniscus suture in com-
bination with implanted cell-free biomaterials revealed no
recognizable healing indicating the development of a crit-
ical size meniscus tear model. In contrast, mesenchymal
stem cells from the bone marrow in combination with
hyaluronan collagen carriers resulted in meniscal repair
Figure 1 Medial meniscus tear and meniscus repair in a right knee joint: Meniscus tear recognized by a probe (upper left); Meniscus
tear preparation with a grasp, which refreshes the tear site (upper right); Meniscus suture with all inside technique (Fast T Fix, Smith
nephew) (lower left); Stable meniscus tear after repair (lower right).
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ology, immunohistochemistry and biomechanical analysis
(Figure 2) (Zellner et al. 2013).
It is not clear whether this is a direct action of the
mesenchymal-based cells or is rather mediated by secre-
tion of certain stimulating factors (Starke et al. 2009).
Despite the fact, that meniscus regeneration seems to be
feasible by growth factors and mononucleated cells,
none of the cell-based strategies has entered clinical
practice to date (Scotti et al. 2013). The implementation
of cell-based strategies is mainly limited by regulatory
burdens and by the necessity to expand cells prior to
transplantation resulting in high treatment costs.Table 1 Mesenchymal stem cells for meniscus
regeneration
Pro/advantages Cons/disadvantages
• High regenerative potential • High treatment costs
• Self renewal capacity • Regulatory burden
• Cellular modulation at lesion site • Missing knowledge of
underlying repair mechanisms
• Potential of differentiation into
meniscal repair cells
• Possible need for cell
expansions prior to application
• Secretion of bioactive substances
like growth factors
• Support/promotion of intrinsic
meniscal healing capacityRegeneration of meniscus defects
Searching for optimal restoration of meniscal tissue, bio-
compatible scaffolds came in the focus for treatment of
large meniscal defects in the last decade. The rationale
for using cell-free biomaterials after extensive loss of
meniscal tissue is based on repopulation of the scaffold
by host cells recruited from the synovium or the menis-
cal remnants (Scotti et al. 2013) (Figure 3).
Two biomaterials are currently in clinical use. The col-
lagen meniscus implant (CMI) was the first scaffold for
meniscus replacement. Some authors report satisfactory
clinical outcome (Rodkey et al. 1999) while MRI and
histological results are controversial. Steadman and
Rodkey (2005) saw a tendency of shrinking over time
and no histological remnants of the collagen scaffold
5–6 years after implantation (Steadman and Rodkey
2005). Martinek et al. (2006) described predominantly scar
tissue formation instead of fibrocartilage after implantation
(Martinek et al. 2006). The second biomaterial is a polyur-
ethane based scaffold called Actifit. The first 12 month re-
port showed tissue ingrowth into the scaffold at this time
and consistent regeneration in MRI and biopsies (Verdonk
et al. 2011).
However, there are no data on the mid- and long term
effects of the CMI or the Actifit on the surrounding car-
tilage in order to prove the beneficial effect on preven-
tion of early onset of osteoarthritis after loss of meniscus
tissue. The amount of the developed repair tissue and its
quality induced by the cell-free implants still seem to be
Table 2 Regenerative treatment options for meniscal lesions
Treatment Pro/Cons
Augmentation of meniscal suture and meniscus reconstruction
by intraarticular microfracturing
+ Easy to perform
+ Adhesion of stem cells at lesion site
- Uncertain effect
- Low concentration of stem cells at defect site
Augmentation of meniscal suture or meniscus cell-free reconstruction
(e.g. Actifit) by locally applied growth factors (e.g. PRP)
+ Application directly at meniscal lesion site
+ High concentration at lesion site
+ Support of intrinsic healing potential
+ One-step-procedure
- Preparation time
- Short term effect at lesion site
- Uncertain local effect
Augmentation of meniscal suture by locally applied MSCs
(e.g. bone marrow derived)
+ High potential differentiation
+ Application directly at meniscal lesion site
+ Support of meniscus regeneration




- Missing knowledge of repair mechanisms
Intraarticular injection of MSCs/growth factors + Adhesion at lesion site
+ Easy to perform
- Uncertain effect
- Low concentration of stem cells at lesion site
- Harvesting and preparation prior to application
- Side effects in the knee joint beside the defect site
Intravascular injection of MSCs + Adhesion at lesion site
- Uncertain effect
- Low concentration of stem cells at lesion site
- Harvesting and preparation prior to application
- Side effects in other areas besides the defect
- No clinical experience
Implantation of MSC loaded carrier/scaffold at meniscal defect site + Potential for treatment of meniscal critical size defects
+ Application directly at meniscal defect site
+ Option for pre-differentiation of MSC/carrier construct
+ Use of autologous cells
- High costs
- Missing knowledge of repair mechanisms
- Necessity of cell expansion prior to implantation/two-step-procedure
- No clinical experience
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of vessels and vascularization into the tip of the new me-
niscus tissue show the need of improvement of this treat-
ment technique. Additionally the biomechanical stability
and the intraoperative handling have to be optimized forbetter clinical results. At the moment the cell-free menis-
cus implants are only used in a very selective group of pa-
tients. Despite promising short term results of meniscal
implants, none of them has currently demonstrated regen-
eration of a functional, long-lasting meniscal tissue.
Figure 2 Treatment of meniscal tears (rabbit) in the avascular zone with a mesenchymal stem cell matrix composite resulted in a
stable repair compared to implantation of a cell free scaffold: Representative macroscopic views, histological (toluidine blue) and
immunohistochemical (collagen type II) slides of menisci and the meniscal repair tissue 3 months after treatment of tears in the
avascular zone: A, B, C: treatment with hyaluronan-collagen composite matrices loaded with mesenchymal stem cells; D, E, F: treatment
with a cell-free composite matrix (control).
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and intact rim of the native meniscus, allogenic meniscal
transplantation is actually the only biologic treatment op-
tion available for totally meniscectomized knee joints
(Lubowitz et al. 2007). A recently published meta-analysis
concluded that this procedure is an effective technique forFigure 3 Meniscus transplantation with cell-free biomaterial after sub
meniscectomy, note the residual meniscus base (upper left); Measurement
right); Insertion of the cell-free biomaterial and fixation with all-inside and othese very selected patients (Elattar et al. 2011). However
fixation of the allograft, the limited availability and the fre-
quent mismatch of graft and host tissue (Shaffer et al.
2000) are still problems of this procedure. In addition,
long term protection from joint degeneration has not yet
been demonstrated (Wirth et al. 2002).total meniscectomy of the medial meniscus (Actifit). Subtotal
of the meniscus defect for preparation of suitable biomaterial (upper
utside-in suture techniques (lower row).
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In experimental trials different settings have been tested for
mesenchymal stem cell based Tissue Engineering ap-
proaches for treatment of meniscus defects (Table 1). Stem
cells can be administered by different ways of application.
In most studies, the local application of mesenchymal stem
cells has been used (Table 2).
Ishimura et al. (1991) showed a faster and improved heal-
ing of avascular meniscal defects in a rabbit model by using
bone marrow fibrin clot constructs compared to fibrin clot
alone (Ishimura et al. 1991). They postulated that the bene-
fit of this treatment is due to the pluripotential stem cells in
the bone marrow. In a scaffold-free engineered meniscal
tissue Aufderheide and Athanasiou (2007) found a high
tensile modulus and improved mechanical properties by a
high density co-culture of fibrochondrocytes and mesen-
chymal stem cells in ring shaped moulds (Aufderheide and
Athanasiou 2007). Despite these reults, for in vivo appli-
cation of mesenchymal stem cells, scaffolds seem to be
a useful tool to ensure a lasting effect of the cells
directly at the defect site. Yamasaki et al. (2008) using
cell-seeded rat decellularized meniscus scaffolds, con-
cluded that cell seeded constructs are more effective than
scaffolds alone (Yamasaki et al. 2008). Multiple natural
and synthetic scaffolds have been used to deliver cells to
the meniscal injury (Sweigart and Athanasiou 2001; Buma
et al. 2004; Scotti et al. 2013). A hyluronan collagen com-
posite matrix were found to be suitable for chondrogenic
differentiation of mesenchymal stem cells (Angele et al.
2009). Treatment of meniscal full size defects with thisFigure 4 Treatment of meniscal defects (rabbit) in the avascular zone
defect filling with a differentiated meniscus like tissue compared to i
views, histological (toluidine blue) and immunohistochemical (collagen
after treatment of circular meniscal punch defects in the avascular zone
loaded with mesenchymal stem cells; D, E, F: treatment with a cell-freescaffold seeded with autologous mesenchymal stem cells
after resection of the pars intermedia of the medial menis-
cus in a rabbit model resulted in a complete defect filling
after 3 months in vivo. Only treatment with mesenchymal
stem cells was able repair this critical size meniscal defects
with stable differentiated meniscus like tissue compared to
untreated defects or the treatment with a cellfree hyaluro-
nan collagen scaffold (Angele et al. 2008). Similar results
were detected for treatment of isolated avascular meniscal
punch defects in the pars intermedia of the lateral menis-
cus in a rabbit model (Zellner et al. 2010). After 3 months
in vivo meniscal defects were filled with differentiated re-
pair tissue after treatment with a hyaluronan collagen
composite matrix seeded with mesenchymal stem cells
(Figure 4). Interestingly precultured stem cell matrix con-
structs showed a reduced integration in the native menis-
cus while non precultured stem cell matrix constructs
resulted in a completely integrated repair tissue indicating
that also the grade of differentiation of the stem cell
matrix construct seems to be an important factor for suc-
cessful treatment of meniscus with stem cell based Tissue
Engineering. In the same model growth factors applied by
autologous PRP failed to repair the avascular meniscal
punch defect. In summary, mesenchymal stem cells seem
to play an essential role for treatment of meniscal defects.
Ethical approval
The experimental studies were performed with permis-
sion of the Ethical comitee at the University Hospital
Regensburg.with a mesenchymal stem cell matrix composite resulted in
mplantation of a cell free scaffold: Representative macroscopic
type II) slides of menisci and the meniscal repair tissue 3 months
; A, B, C: treatment with hyaluronan-collagen composite matrices
composite matrix (control).
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Tissue Engineering of meniscus with mesenchymal based
cells seems to be a promising approach to treat meniscal
tears and defects in order to restore as much native
meniscal tissue as possible. In preclinical trials, treatment
of meniscus tears only with suture or meniscus defects
with cell-free biomaterials, which both represent the ac-
tual clinical practice, fail to show comparable results to
mesenchymal cell based approaches.
Despite the fact, that meniscus regeneration seems to
be feasible by growth factors and mesenchymal stem
cells, none of the cell-based strategies has entered clin-
ical practice to date. The implementation of cell-based
strategies is mainly limited by regulatory burdens and by
the necessity to expand cells prior to transplantation
resulting in high treatment costs.
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